Achilleas Thoma1, Manraj Nirmal Kaur2, Teegan Aili Ignacy3, Carolyn Levis4, Stuart Martin4, Eric Duku5, Ted Haines6. 1. Division of Plastic Surgery, Department of Surgery, McMaster University, 1280 Main Street West, Hamilton, ON Canada ; Surgical Outcomes Research Centre, Department of Surgery, McMaster University, 1280 Main Street West, Hamilton, ON Canada ; Department of Clinical Epidemiology & Biostatistics, McMaster University, 1280 Main Street West, Hamilton, ON Canada ; Suite 101, 206 James Street South, Hamilton, ON Canada L8P 3A9. 2. Division of Plastic Surgery, Department of Surgery, McMaster University, 1280 Main Street West, Hamilton, ON Canada ; Surgical Outcomes Research Centre, Department of Surgery, McMaster University, 1280 Main Street West, Hamilton, ON Canada. 3. Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St, Toronto, ON Canada. 4. Division of Plastic Surgery, Department of Surgery, McMaster University, 1280 Main Street West, Hamilton, ON Canada. 5. Offord Centre for Child Studies, Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1280 Main Street West, Hamilton, ON Canada. 6. Department of Clinical Epidemiology & Biostatistics, McMaster University, 1280 Main Street West, Hamilton, ON Canada.
Abstract
BACKGROUND: The traditional outcome measured following treatment of Dupuytren's Disease (DD) has been digital range of motion; specifically the gain in digital extension. The outcomes research movement in the last three decades however has been advocating the measurement of outcomes from the patient's perspective using Health-Related Quality of Life questionnaires (HRQOL). Although several generic and region-specific HRQOL questionnaires exist, there is no guidance as to which one is the most appropriate for this population. The objective of this study is to evaluate the psychometric properties of three self-reported HRQOL outcome measures in patients with DD. METHODS: Patients with DD were enrolled from the practices of three plastic surgeons. Test-retest reliability, concurrent validity and responsiveness of three HRQOL questionnaires were compared in a prospective study design. The HRQOL measures included Health Utilities Index Mark 3 (HUI3), Short Form-36 (SF-36), and the Michigan Hand Questionnaire (MHQ). RESULTS: All three measures demonstrated good test-retest reliability (ICC = 0.77-0.85). Concurrent validity was found between the HUI3 pain and dexterity attributes and SF-36 physical summary score. The sensitivity of the MHQ to detect changes in the status of the patient was found to be high (effect size = 1.14) whereas that of the SF-36 was trivial. CONCLUSIONS: The HUI3 and the MHQ seem to be reliable and valid tools to assess the HRQOL in patients with Dupuytren's Disease.
BACKGROUND: The traditional outcome measured following treatment of Dupuytren's Disease (DD) has been digital range of motion; specifically the gain in digital extension. The outcomes research movement in the last three decades however has been advocating the measurement of outcomes from the patient's perspective using Health-Related Quality of Life questionnaires (HRQOL). Although several generic and region-specific HRQOL questionnaires exist, there is no guidance as to which one is the most appropriate for this population. The objective of this study is to evaluate the psychometric properties of three self-reported HRQOL outcome measures in patients with DD. METHODS:Patients with DD were enrolled from the practices of three plastic surgeons. Test-retest reliability, concurrent validity and responsiveness of three HRQOL questionnaires were compared in a prospective study design. The HRQOL measures included Health Utilities Index Mark 3 (HUI3), Short Form-36 (SF-36), and the Michigan Hand Questionnaire (MHQ). RESULTS: All three measures demonstrated good test-retest reliability (ICC = 0.77-0.85). Concurrent validity was found between the HUI3 pain and dexterity attributes and SF-36 physical summary score. The sensitivity of the MHQ to detect changes in the status of the patient was found to be high (effect size = 1.14) whereas that of the SF-36 was trivial. CONCLUSIONS: The HUI3 and the MHQ seem to be reliable and valid tools to assess the HRQOL in patients with Dupuytren's Disease.
Entities:
Keywords:
Dupuytren’s Disease; Outcomes; Palmar fasciectomy; Quality of life
Authors: Justin C R Wormald; Luke Geoghegan; Kyra Sierakowski; Andrew Price; Michele Peters; Abhilash Jain; Jeremy N Rodrigues Journal: Plast Reconstr Surg Glob Open Date: 2019-05-21